We have used a murine model of organ-specific autoimmunity to characterize therapeutic modalities capable of downregulating the cellular limb of the autoimmune response. Murine interstitial nephritis is an autoimmune disease mediated by tubular antigen-specific CD8+ nephritogenic effector T cells which are delayed-type hypersensitivity (DTH) 
Introduction
The development of immunosuppressive modalities targeting injurious cellular immune responses has enormous intrinsic appeal as well as broad potential clinical applications. Several approaches to the development of such modalities have been taken in both autoimmune disease models and experimental transplant rejection. For example, immunosuppressive modalities which target only some T cell phenotypes (1-3), cellsurface determinants preferentially expressed on activated T cells (4, 5) , or restricted T cell receptor (TCR)' variable regions (6) (7) (8) (9) are efficacious therapies for several experimental autoimmune diseases. An ideal immunosuppressive modality, however, would be antigen or clone specific, targeting only those T cells involved in the autoimmune, or alloreactive, response. This type of immunosuppression could theoretically be achieved through preferential expansion of specific suppressor T cells in the host.
Studies performed in several autoimmune disease models induced by immunization have demonstrated that alternate means of antigen presentation can preferentially induce the expansion of T cells which inhibit disease expression. These techniques include immunization with large amounts of antigen in incomplete Freund's adjuvant (10, 11) , or intravenous injection of antigen chemically coupled to splenocytes (12) (13) (14) . The latter method is one initially used to induce hapten-specific suppressor T cells (15, 16) . In a murine model of autoimmune kidney disease, anti-tubular basement membrane (aTBM) disease, intravenous injection of tubular antigen coupled to splenocytes prevents the characteristic inflammatory lesion in the renal interstitium and also improves the histologic lesion in animals with established disease ( 17, 18) . The adoptive transfer of specific T cell populations from the recipients of tubular antigencoupled splenocytes inhibits induced T cell responses to tubular antigen and the histologic expression of disease, strongly supporting the hypothesis that Ts cells are an important component of this immunosuppression (18) .
The intravenous injection of tubular antigen-coupled splenocytes into SJL mice (H-2S) induces two phenotypically and functionally distinct populations of Ts cells (18) . The CD4+ suppressor T cells (Tsl ) inhibit an early stage in the differentiation of the nephritogenic CD8 + effector T cells which mediate aTBM disease, and also induce a population of CD8 + suppressor T cells (18) (19) (20) . These CD8+ Ts cells (Ts2), or soluble proteins secreted by Ts2 cells (TsF2), directly inhibit the function of bulk populations of tubular antigen-specific CD8+ effector cells through a noncytotoxic mechanism ( 18, 19) . While the molecular definition of suppressor factors is still controver-sial, increasing evidence supports their being closely related to conventional TCR chains (21) (22) (23) (24) .
We have been interested in developing highly targeted immunotherapy for autoimmune disease and in delineating the cellular and molecular events which define a "suppressed" T cell. We have recently characterized a panel of nephritogenic effector T cell clones specific for 3M-1, a glycoprotein target antigen of aTBM disease (25, 26) . These cultured CD8+ T cells, called M52, maintain the functional capacity of nephritogenic effector T cells induced in vivo (26) . Class I MHCrestricted M52 cells mediate 3M-i-specific delayed-type hypersensitivity (DTH) and cytotoxic responses, and adoptively transfer interstitial nephritis to naive syngeneic recipients. Analysis of M52 clones has revealed two distinct functional subsets within the M52 cell line. One subset is cytotoxic and not DTH reactive to the target antigen 3M-1. The other subset is DTH reactive but effects less efficient cytotoxicity to 3M-i-expressing tubular epithelial cells (26) . Since previous studies suggest that these clones should be the direct target of TsF2 (18, 19) , we were in a unique position to characterize the state of clonal inactivation resulting from coculture with a suppressor factor. Our studies show that co-culture with TsF2 results in functional inactivation of nephritogenic M52 cells. TsF2 inhibits both cytotoxic and DTH-reactive clones and abrogates the nephritogenic potential of M52 cells in adoptive transfer studies. This inhibitory activity is specific for M52 cells. Metabolic inhibitor studies indicate that TsF2-induced suppression of M52 is dependent on new mRNA and protein synthesis. In the cytotoxic clone, one of these induced mRNA species is TGF-f1i, which is required for TsF2-induced suppression of cytotoxicity and nephritogenicity.
Methods
Mice. SJL mice (H-2') were purchased from the Jackson Laboratory (Bar Harbor, ME).
Antigens and antibodies. Rabbit renal tubular basement membranes were isolated by a differential sieving technique, sonicated, lyophilized, and stored at -20°C (27) . Soluble renal tubular antigen (SRTA) was made from these lyophilized membranes by collagenase digestion (28) . The nephritogenic moiety in this digestion, the 3M-I glycoprotein, is purified from SRTA using immunoaffinity chromatography with a mAb (25) . P1, a synthetic peptide derived from the cDNA sequence of 3M-1 (LLRRRHGDRRSTMSAEVP) was manually synthesized by the simultaneous multiple peptide method of Houghten (29, 30 T cell lines (M52 and M61) and clones. CD8+ T cell lines and clones were isolated from immunized mice as previously described (26) and propagated by weekly passage with 20 jig/ml antigen (SRTA, P1, or PPD), 20% MLA-144 supernatants as a source or IL-2 and other growth factors (31) (19, 20) . Induced splenocytes were then depleted with aCD4 Ab (from GK 1.5 hybridoma [33] ) and a mixture of guinea pig and rabbit C. Freezethaw lysates were made of the remaining CD8+ T cells. For some studies, control lysates of induced CD4+ and other CD8+ cells were prepared similarly. Lysates of CD4' T cells induced by TsF1 were prepared after incubation of induced splenocytes with aCD8 Ab (from hybridoma 3.168.8 [34] ) and C. The other control lysate was made from CD8+ T cells induced by supernatants of CD4+ Th cells (M30F) (35) . After a 5-d coculture of M30F with syngeneic splenocytes, T cell medium, SRTA (20 ,g/ml), and MLA-144 supernatants, CD8+ T cells were isolated by depletion with aCD4 Ab and C. These lysates were quantitated in cell equivalents, i.e., a lysate derived from 5 x 106 cells was described as 5 x 106 cell equivalents. In some studies, these lysates were added to day 3 cultured T cells (0.5 X 106 cell equivalents added per well of a 24-well plate), and 24 h later cultures were washed and replated in fresh T cell medium, IL-2, and antigen. Cells were harvested for functional studies or RNA extraction on day 7 of culture.
Local adoptive transfer of DTH. The adoptive transfer of DTH has been described in detail (26, 36) . In brief, cultured T cells were washed and resuspended at 2.0 x 10' cells/ml in 1 mg/ml of SRTA, PPD, P1, or PBS, and 25 ILI of each cell preparation were injected into the hind footpad of recipient mice (3-4 mice/group). Footpad swelling as an index of DTH was measured 24 h later using a spring-loaded engineer's micrometer (model 7308; Mitutoyo/MTI Corp., Paramus, NJ). The magnitude of swelling was expressed as the mean increment between the antigen-challenged footpad and that injected with PBS in inches x 10-3+SEM. In some experiments, T cell subpopulations were selectively depleted by incubation with aCD8 or aCD4 mAb and C. All footpad measurements were performed by an individual blinded to the experimental protocol.
Adoptive transfer of disease. These adoptive transfers have been previously described (26, 36 (26, 36) : 0, no involvement from the subcapsular cell layer; 0.5, trace pathologic changes of cellular involvement in a focal pattern in the outermost cortical tubular area; 1, superficial, focal peritubular infiltration and tubular atrophy under the transferred cell layer; 2, focal, deeply extending, heavy cellular infiltrates with peritubular damage and tubular atrophy. The sections were also graded by approximating the tubular layer cell depth of the infiltrating front of mononuclear cells. Each layer equalled a tubular diameter and was given one point. The data from both methods were expressed as a mean for each group±SEM.
Cytotoxicity assays. This method determines target cell viability (37, 38) , and has been described in detail previously (26) . In brief, the MCT target cells were prepared from confluent cultures by light trypsinization from tissue culture flasks and washed once in serum-containing medium. Cells were then resuspended at 1.0 x 106/ml in medium containing 0.5 Asg/ml mitomycin C (Sigma Chemical Co.), vigorously vortexed and then 20-yl aliquots were dispensed into 96-well flat-bottomed (42) . The extracted RNA was washed with 80% ethanol, vacuum-dried and resuspended in diethyl pyrocarbonate-treated water. After assessing the purity of the final products by optical density ratios at 260:280 nm, which were typically > 1.7, the RNA samples were then used for Northern blot analyses or reverse transcribed into cDNA for the polymerase chain reaction. Northern blot hybridization. Total RNA isolated from 6 x 106 T cells was fractionated on a 1.5% agarose-formaldehyde gel and then transferred to a Zetabind membrane (Cuno Inc., Meriden, CT). Prehybridization and hybridization were conducted at 550C in 0.5 M Na2PO4 buffer, 7% SDS, 1% BSA, and 1 mM EDTA with 50 ug/ml polyadenylic acid (Boehringer Mannheim Biochemicals, Indianapolis, IN) and 50-100 jg/ml sheared salmon sperm DNA. Blots were hybridized to 32P-labeled (random-primed) murine probes (specific activity of 2.0 X 109 dpm/jg) for 16 h at 550C. Probes for TCR Cli (43) of denaturation at 920C for 1 min, primer annealing at 50C for 1 min, and extension at 720C for 2 min. 10 jil of each PCR reaction mixture was electrophoresed in a 2% agarose gel. Gels were stained with ethidium bromide and photographed.
Oligonucleotides usedfor amplification. Oligonucleotides were synthesized on a DNA synthesizer (Applied Biosystems, Foster City, CA). The sense (5' primer) and antisense (3' primer) sequences used for these PCR reactions and the source of the published murine cytokine sequences are as listed in Table I (Table II) . This phenomenon is examined in more detail below.
We also tested the effects of TsF2 on M52 clones. As previously stated, the CD8+ M52 cell line is comprised of two functionally distinct phenotypes. One subset is cytotoxic and not DTH reactive to tubular antigen and one is DTH reactive and mediates less efficient cytotoxicity to tubular epithelial cells. We cocultured three DTH-reactive M52 clones with TsF2. As seen in Table III (26) . In the present studies we confirmed the nephritogenicity of M52 cells (Fig. 2, A and B, Table IV ). The recipients of these cells were sacrificed 7 d after cell transfer and the kidneys evaluated by light microscopy for both severity of injury and maximum depth of the infiltrating cell front (26, 36) . Areas of involvement in these kidneys consisted of focal mononuclear infiltrates as well as areas of tubular atrophy and dilatation. In contrast to these lesions, adoptive transfer of TsF2-treated cells did not In addition, cytofluorographic analyses of TsF2-pulsed M52 clones demonstrate persistent cell surface expression of af3 TCR (Fig. 4) , unchanged in intensity from that previously reported for active M52 clones (26) . FACS analyses of these clones also demonstrated unchanged IL-2R expression (Fig. 5) (Fig. 6 A) , but even with such a highly sensitive technique we could not demonstrate the presence of a perforin transcript. The cytotoxic clone, M52.26, con- sistently displayed a different pattern of cytokine expression, as shown in Fig. 6 a reduction of IFN--y expression in TsF2-treated DTH-reactive clones. Fig. 7 B shows the induction of TGF-f3 and the loss of perforin and IFN-'y in the cytotoxic clone, M52.26. The lack of IL-2 expression in the DTH-reactive clones is also apparent. 
Discussion
The concept that T cells can be functionally inhibited in an antigen-or clone-specific manner by the product of another T cell is certainly not a novel one. A number of investigators have described this phenomenon and have distinguished the effects of antigen-specific suppressor factors (TsFs) from nonspecific inhibitory cytokines (such as TGF-/3) as well as from cytotoxicity or the absence of help (55) (56) (57) . Research in the area of antigen-specific suppression became highly controversial in the 1980's, when Ts hybridomas were shown not to express conventional TCR (58) and the molecular definition of TsFs remained unclear. In the past several years though, investigators working in several distinct antigenic systems have unequivocally demonstrated the presence of conventional ac3 TCR on Ts hybridomas and clones (23, 56, 59) . Recent studies strongly support a longstanding hypothesis that these suppressor factors are comprised, at least in part, of conventional TCR polypeptides (21, 22, 24, 59 ). These findings have rekindled an interest in exploring the potential of antigen-specific immunosuppression for the therapy of autoimmune disease and transplant rejection.
Evidence that regulatory T cells can have a profound impact on both histologic abnormalities and functional organ impairment exists in several models of autoimmunity, including a!TBM disease (11, 17, 18, 20, 60) , interstitial nephritis in kdkd mice (61) , insulin-dependent diabetes in NOD mice (62, 63) , thyroiditis (10, 64) , and experimental allergic encephalomyelitis (EAE) (12, 14, 65) . How Ts cells function to impair autoimmune T and/or B cell clones is less clear. Previous work in murine aTBM disease demonstrated that bulk populations of the CD8 + effector T cells could be functionally inhibited in a noncytotoxic manner by CD8+ splenocytes (or cell lysates) from recipients of Ag-coupled splenocytes (18) . In this study we used four previously characterized nephritogenic T cell clones (26) to more closely examine the mechanism of their inactivation.
We first confirmed that the inhibitory effect of the cell lysate, TsF2, is specific for the M52 clones and also not a nonspecific effect of a lysate preparation. TsF2 functionally inhibits both cytotoxic clones and DTH-reactive clones and, perhaps most importantly, the ability of these T cells to elicit an inflammatory response in the interstitium of the kidney after adoptive transfer. Previous studies in this model demonstrated that the CD8 + Ts cells and TsF2 are anti-idiotypic and that this might provide a structural basis for their interaction with idiotypeexpressing CD8 + effector T cells ( 18) . The recent observations from the rat model of EAE that TCR V138 region peptides can induce or augment anti-V/38 T cells and antibodies provides a structural basis for such an idiotypic-antiidiotypic interaction as well as another example of how this interaction can be immunosuppressive in the setting of organ-specific autoimmunity (7, 8) . In EAE the encephalitogenic T cells preferentially utilize the V/8.2 gene (6, 66) and therefore induced anti-V/38 immune responses can effectively target the majority of encephalitogenic clones. The target of TsF2 may be intact M52 TCR or processed TCR peptides. We are presently investigating the V regions used by these clones.
Although we were initially impressed that exposure to TsF2 induced an indefinite state of unresponsiveness, this finding is consistent with the complete inhibition of nephritogenic T cell expression and disease activity documented in previous studies (18) (19) (20) . The fact that the cell line and clones continued to grow well immediately after exposure to TsF2 and when repassaged, led us to examine whether we could identify some alteration in cell-surface receptors or cytokine expression which might explain their inability to function. While we cannot rule out an alteration in a cell-surface molecule, TCR (68) (69) (70) . The induction phase of unresponsiveness in these systems is also an active process requiring new protein synthesis, as it can be blocked by cycloheximide (70) . It is interesting that a critical event in these anergic CD4+ clones appears to be the marked reduction in IL-2 production after T cell activation although IL-2R expression is maintained, as are normal levels of TCR expression (68, 69 (80, 81) . It is quite plausible that once TsF2 has induced TGF-,/ expression in a T cell such as M52.26, the clone in effect inactivates itself. Such a regulatory mechanism in vivo could locally downregulate T cell-mediated responses and disease activity. This explanation, however, does not apply to clones such as M52.34, which expresses TGF-3il following activation and are not inactivated by exogenous TGF-3L1. The mechanism by which TsF2 inactivates such clones is under active investigation.
